First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

NCT05627960 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
77
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

A&G Pharmaceutical Inc.

Collaborators